Convergence Investment Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.13M | Buy |
|
|||||
|
2025
Q1 | $5.96M | Sell |
|
|||||
|
2024
Q4 | $6.32M | Buy |
|
|||||
|
2024
Q3 | $4.96M | Buy |
|
|||||
|
2024
Q2 | $3.49M | Sell |
|
|||||
|
2024
Q1 | $3.74M | Buy |
|
|||||
|
2023
Q4 | $3.7M | Sell |
|
|||||
|
2023
Q3 | $3.69M | Sell |
|
|||||
|
2023
Q2 | $3.81M | Sell |
|
|||||
|
2023
Q1 | $4.22M | Sell |
|
|||||
|
2022
Q4 | $4.37M | Buy |
|
|||||
|
2022
Q3 | $3.09M | Buy |
|
|||||
|
2022
Q2 | $1.95M | Sell |
|
|||||
|
2022
Q1 | $2.05M | Buy |
|
|||||
|
2021
Q4 | $2.48M | Buy |
|
|||||
|
2021
Q3 | $2.32M | Buy |
|
|||||
|
2021
Q2 | $1.92M | Sell |
|
|||||
|
2021
Q1 | $2.06M | Buy |
|
|||||
|
2020
Q4 | $1.85M | Sell |
|
|||||
|
2020
Q3 | $4.1M | Sell |
|
|||||
|
2020
Q2 | $5.19M | Buy |
|
|||||
|
2020
Q1 | $4.76M | Buy |
|
|||||
|
2019
Q4 | $4.04M | Sell |
|
|||||
|
2019
Q3 | $4.02M | Buy |
|
|||||
|
2019
Q2 | $2.13M | Buy |
|
|||||
|
2019
Q1 | $2.04M | Buy |
|
|||||
|
2018
Q4 | $1.95M | Buy |
|
|||||
|
2018
Q3 | $2.03M | Buy |
|
|||||
|
2018
Q2 | $1.34M | Sell |
|
|||||
|
2018
Q1 | $2.35M | Sell |
|
|||||
|
2017
Q4 | $6.74M | Buy |
|
|||||
|
2017
Q3 | $7.62M | Buy |
|
|||||
|
2017
Q2 | $3.95M | Sell |
|
|||||
|
2017
Q1 | $6.8M | Buy |
|
|||||
|
2016
Q4 | $4.34M | Buy |
|
|||||
|
2016
Q3 | $3.37M | Sell |
|
|||||
|
2016
Q2 | $8.45M | Sell |
|
|||||
|
2016
Q1 | $11.1M | Sell |
|
|||||
|
2015
Q4 | $12.9M | Buy |
|
|||||
|
2015
Q3 | $12.5M | Sell |
|
|||||
|
2015
Q2 | $15M | Buy |
|
|||||
|
2015
Q1 | $7.08M | Sell |
|
|||||
|
2014
Q4 | $7.05M | Sell |
|
|||||
|
2014
Q3 | $8.31M | Buy |
|